Oscotec Inc. (KOSDAQ:039200)
South Korea · Delayed Price · Currency is KRW 38,850
+750 (1.97%)
Aug 20, 2026, 3:30 PM KST
Oscotec Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 101,550 | 99,839 | 34,008 | 4,951 | 5,062 | 3,903 |
Revenue Growth | 191.13% | 193.58% | 586.89% | -2.20% | 29.71% | -91.02% |
Gross Profit Gross Profit Growth | 99,254 | 97,687 | 31,436 | 2,747 | 2,839 | 1,768 |
Operating Income Operating Income Growth | 50,414 | 52,081 | -2,734 | -32,655 | -28,638 | -28,097 |
Net Income Net Income Growth | 55,559 | 52,343 | 876.53 | -24,280 | -24,430 | -26,263 |
Earnings Per Share EPS Growth | 1452.76 | 1368.00 | 22.92 | -635.00 | -763.19 | -866.00 |
EPS Growth | - | 5868.90% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
New Drug Business Division New Drug Business Division Growth | 98,121 | 96,676 | 30,260 | 1,287 | 1,123 | - |
Medical Business Sector Medical Business Sector Growth | 1,858 | 1,778 | 2,275 | 2,617 | 2,737 | 2,735 |
Food Business Food Business Growth | 1,281 | 1,101 | 1,074 | 751.48 | 801.64 | 699.53 |
Functional Materials Functional Materials Growth | 289.42 | 283.37 | 398.2 | 295.24 | 401 | - |
Total Total Growth | 101,550 | 99,839 | 34,008 | 4,951 | 5,062 | 3,903 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 158,503 | 108,087 | 102,728 | 97,481 | 103,696 | 14,584 |
Total Debt Total Debt Growth | 16,931 | 15,618 | 13,816 | 24,612 | 10,085 | 7,252 |
Net Cash (Debt) Net Cash Growth | 141,571 | 92,469 | 88,912 | 72,868 | 93,611 | 7,333 |
Net Cash Growth | 24.41% | 4.00% | 22.02% | -22.16% | 1176.64% | -72.23% |
Net Cash Per Share Net Cash Per Share Growth | 3702.75 | 2417.37 | 2324.81 | 1905.34 | 2924.46 | 241.76 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 30,870 | 8,302 | -26,034 | -22,048 | -26,421 | -8,762 |
Capital Expenditures CapEx Growth | -1,213 | -779.65 | -623.78 | -581.22 | -1,249 | -7,518 |
Free Cash Flow Free Cash Flow Growth | 29,657 | 7,523 | -26,657 | -22,629 | -27,670 | -16,280 |
Free Cash Flow Growth | 534.42% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 97.74% | 97.84% | 92.44% | 55.49% | 56.08% | 45.30% |
Operating Margin | 49.64% | 52.16% | -8.04% | -659.58% | -565.71% | -719.93% |
Pretax Margin | 54.74% | 52.87% | -3.29% | -652.07% | -552.76% | -732.38% |
Profit Margin | 54.71% | 52.43% | 2.58% | -490.40% | -482.57% | -672.93% |
FCF Margin | 29.20% | 7.54% | -78.39% | -457.06% | -546.58% | -417.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 26.74 | 33.04 | 1067.90 | - | - | - |
Forward PE | 46.20 | 48.46 | 73.96 | 69.40 | 69.40 | 69.40 |
P/FCF Ratio | 50.12 | 229.87 | - | - | - | - |
PS Ratio | 14.64 | 17.32 | 27.52 | 177.78 | 129.49 | 284.45 |